Literature DB >> 646969

The comparative effects of a synthetic and a 'natural' oestrogen on the haemostatic mechanism in patients with primary amenorrhoea.

J L Toy, J A Davies, K W Hancock, G P McNicol.   

Abstract

A synthetic and a natural oestrogen were administered alternately for three months to nine women with primary amenorrhoea using a randomized cross-over schedule. Measurements of haemostatic function were performed before and at the end of each treatment period. No significant change in haemostatic function was observed after treatment with the 'natural' oestrogen, oestriol succinate. In contrast, treatment with a synthetic oestrogen, ethinyloestradiol, caused shortening of the prothrombin time and an increase in plasma concentration of factor VII and plasminogen. These data support other observations in suggesting that natural oestrogens may have fewer potentially adverse effects on haemostatic function than synthetic oestrogen.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 646969     DOI: 10.1111/j.1471-0528.1978.tb14894.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  5 in total

1.  Emboli from a prosthetic heart valve during postmenopausal oestrogen therapy.

Authors:  D Pitcher; P Curry
Journal:  Br Med J       Date:  1979-07-28

2.  Hormone replacement therapy and its influence on AT-III activity in climacteric women.

Authors:  H Enzelsberger; G Heytmanek; C Kurz; M Metka
Journal:  Klin Wochenschr       Date:  1991-03-18

3.  Effects of protracted administration of estriol on the lower genito urinary tract in postmenopausal women.

Authors:  C S Iosif
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

4.  Transdermal estradiol substitution therapy for the induction of puberty in female hypogonadism.

Authors:  M Cisternino; K Nahoul; M Bozzola; G Grignani; G Perani; P Sampaolo; M Roger; F Severi
Journal:  J Endocrinol Invest       Date:  1991-06       Impact factor: 4.256

Review 5.  An overview of the development of combined oral contraceptives containing estradiol: focus on estradiol valerate/dienogest.

Authors:  Franca Fruzzetti; Florence Trémollieres; Johannes Bitzer
Journal:  Gynecol Endocrinol       Date:  2012-04-02       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.